Estudo de produção enzimatica da dextrana clinica

AUTOR(ES)
DATA DE PUBLICAÇÃO

1993

RESUMO

This study consists of the "in vitro" production of clinical dextran from sucrose using the enzyme dextransucrase obtained from Leuconostoc mesenteroides NRRl B512-F. Clinical dextran, whose average molecular weight is 40,000 daltons, is extensively used as a volume expander of human blood. The enzyme was produced by fermentation; purified by ultracentrifugation, separated using polyethylene glycol (mol. weight 1500 daltons) and stored at -10°C. The study of the production of clinical dextran was carried out according to the two steps of synthesis, an experimental design being produced for each step. In the first step maltose was used as an acceptor and in the second, dextran with a molecular weight of 4676 daltons. The objective of the first design was to optimize the conditions to obtain dextran with a molecular weight of about 5000 daltons, and the second design ained at obtaining the actual clinical dextran. The yield and the molecular weight distribution of the dextran produced was determined by a high performance gel permeation chromatography system (HPLC). The results of the process for the enzymatic synthesis of dextran were used to obtain models for the yield and the molecular weight distribution as conditions of sucrose concentrations, the ratio R and temperature. Using surface response methodology, it was conclucted that the sucrose concentration was the variable that most affected . the enzymatic synthesis of dextran. The parameters required to produced greater yields of dextran with a molecular weight of about 40,000 daltons were: high concentrations of sucrose (133,7 g/l), low temperatures (18,3°C) and high values to the relationship R (acceptor]/[sucrose]) of 0,0384

ASSUNTO(S)

polissacarideos - sintese enzimas - sintese dextrano - sintese

ACESSO AO ARTIGO

Documentos Relacionados